BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, July 4, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Financings: Varian authorizes repurchase of an additional 8 million shares

Nov. 24, 2015

Patent Watch: Neurometrix patent covers nerve condition test

Nov. 24, 2015

Briefly noted

Nov. 24, 2015

Product briefs

Nov. 24, 2015

MDD's Cardiology Extra

Nov. 24, 2015
By Amanda Pedersen

Treasury Rules: Unlikely to Stop Merger: It's official: Pfizer, Allergan combining in stock-based $160B tax inversion deal

Nov. 24, 2015
By Cormac Sheridan
DUBLIN – Pfizer Inc. (New York) is swapping its New York home for an Irish domicile by combining with Allergan plc (Dublin) in an all-share deal, which values the latter firm at $160 billion and which will cut Pfizer's tax rate from its reported rate of 25.5 percent in 2014 to 17 percent to 18 percent for the combined company.
Read More

Product briefs

Nov. 23, 2015

MDD's Neurology Extra

Nov. 23, 2015
By Robert Kimball

Daily M&A: Bard to enhance position in home care market with $181M Liberator acquisition

Nov. 23, 2015
By Omar Ford
Liberator Medical Holdings Inc. (LBMH; Stuart, Fla.) shares (NASDAQ:LBMH) soared 25 percent in heavy trading Friday, closing at $3.34 a share, on the news that C. R. Bard Inc. (Murray Hill, N.J.) is buying the company for $3.35 per share, or about $181 million. The transaction is expected to close in 1Q16.
Read More

Inside the Beltway: CAFC rules for Ariosa against Verinata, remands case to PTAB

Nov. 23, 2015
By Mark McCarty
Previous 1 2 … 2779 2780 2781 2782 2783 2784 2785 2786 2787 … 10252 10253 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 2, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 30, 2026
  • Black wavy lines forming an abstract sound wave.png

    Deep brain stimulation from the shallows: tomorrow’s BCI technology?

    BioWorld
    Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
  • AI-generated image for brain organoid neural research

    CINP 2026: organoids reveal autism and addiction mechanisms

    BioWorld Science
    At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
  • Handshake, businessmen holding dollar sign, lightbulb

    Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal

    BioWorld
    A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing